Atlas FDA

CONSULTA ICD & BRAVA, CONCERTO II, MAXIMO II,PROTECTA/PROTECTA XT, VIVA S/XT CRT- D'S

FDA premarket approval P010031/S389 · decided 2013-08-12

Approval details

PMA number
P010031
Supplement
S389
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
CONSULTA ICD & BRAVA, CONCERTO II, MAXIMO II,PROTECTA/PROTECTA XT, VIVA S/XT CRT- D'S
Applicant
Medtronic Cardiac Rhythm Disease Management
Date received
2013-07-17
Decision date
2013-08-12
Days to decision
26 days
Decision code
OK30
Advisory committee
Cardiovascular
Expedited review
No
Location
Mounds View, MN
Statement
CHANGE FOR AN INCOMING MATERIAL ACCEPTANCE PROCEDURE FOR UNDERFILL CURE EPOXY.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.